Background: Using more than one therapeutic approach in the treatment of basal cell carcinomas (BCCs) has the potential to enhance cure rates. Materials and Methods: In this study, 57 nodular and superficial BCCs were curetted without electrodesiccation. One week later, imiquimod 5% cream therapy was initiated once daily 5 times per week for 6 weeks. At 1-year follow-up, 0 of 57 BCCs (0%) had clinical recurrences. Cosmetic results were very good to excellent. Conclusion: Combination therapy with imiquimod 5% cream followed by curettage represents an effective method for treating BCCs with a high cure rate.
|Journal||Journal of Drugs in Dermatology|
|State||Published - Jan 2008|